Alyeska Investment Group’s Array Biopharma Inc ARRY Stock Holding History

Alyeska Investment Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-891,682	Closed	-$41.3M	–	562
2019 Q2	$41.3M	Buy	+891,682	New	+$25M	0.53%	61
2019 Q1	–	Sell	-248,000	Closed	-$3.53M	–	487
2018 Q4	$3.53M	Sell	248,000 -265,417	-52%	-$4.03M	0.05%	251
2018 Q3	$7.8M	Buy	513,417 +129,295	+34%	+$1.98M	0.09%	203
2018 Q2	$6.45M	Buy	384,122 +210,684	+121%	+$3.35M	0.06%	256
2018 Q1	$2.83M	Buy	+173,438	New	+$2.78M	0.02%	327

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Alyeska Investment Group's ARRY Position: Q3 2019 in Review

Alyeska Investment Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 891,682 shares — an estimated $41.3M sold.

Alyeska Investment Group first reported a position in ARRY in Q1 2018 and held it in 5 quarters. The position peaked at $41.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Alyeska Investment Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Alyeska Investment Group sold 891,682 Array Biopharma Inc shares in Q3 2019, an estimated $41.3M.
Alyeska Investment Group first reported a position in Array Biopharma Inc in Q1 2018 and held it in 5 quarters.
Alyeska Investment Group's Array Biopharma Inc position peaked at $41.3M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.